Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Down 13.0% in February

Rockwell Medical, Inc. (NASDAQ:RMTI) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 438,800 shares, a decrease of 13.0% from the January 31st total of 504,200 shares. Based on an average daily volume of 414,700 shares, the short-interest ratio is currently 1.1 days. Approximately 1.6% of the company’s shares are short sold.

Rockwell Medical Trading Down 3.0 %

Shares of Rockwell Medical stock opened at $1.60 on Friday. The company’s fifty day simple moving average is $1.97 and its 200-day simple moving average is $2.72. The stock has a market capitalization of $51.71 million, a PE ratio of -32.00 and a beta of 1.39. Rockwell Medical has a 1-year low of $1.35 and a 1-year high of $5.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00.

Analyst Ratings Changes

Several brokerages have commented on RMTI. StockNews.com lowered shares of Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a research report on Thursday, November 14th. HC Wainwright reissued a “buy” rating and set a $7.00 price target on shares of Rockwell Medical in a research report on Monday, December 23rd. Finally, Rodman & Renshaw began coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They set a “buy” rating and a $5.00 price target for the company.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of RMTI. Beacon Financial Advisory LLC purchased a new position in shares of Rockwell Medical during the 3rd quarter worth $98,000. Concurrent Investment Advisors LLC purchased a new position in shares of Rockwell Medical during the 3rd quarter valued at $40,000. Verus Capital Partners LLC purchased a new position in shares of Rockwell Medical during the 3rd quarter valued at $51,000. Corsair Capital Management L.P. purchased a new position in shares of Rockwell Medical during the 3rd quarter valued at $298,000. Finally, Walleye Capital LLC purchased a new position in shares of Rockwell Medical during the 3rd quarter valued at $435,000. Hedge funds and other institutional investors own 23.31% of the company’s stock.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.